Back to Search
Start Over
Figure S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Correlation analysis of PI3Kd levels and the response to IOA-244 and Idelalisib
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c3ad4e870e407c9d90a2748ef9601c6a